Trials / Conditions / Lymphocytic
Lymphocytic
3 registered clinical trials studyying Lymphocytic.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia NCT03759184 | National Cancer Institute (NCI) | Phase 1 |
| Completed | A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer NCT01149668 | Pharmacyclics LLC. | Phase 1 |
| Completed | Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia NCT00077922 | National Cancer Institute (NCI) | Phase 2 |